Significance of matrix metalloproteinase 9 and CD34 expressions in esophageal carcinoma: Correlation with DNA content

Journal of Clinical Gastroenterology

Volumn 39, Issue 9, 2005, Pages 791-794

  El Kenawy, Ayman El Meghawry ^a   Lotfy, Mahmoud ^a   El Kott, Attalla ^b   El Shahat, Mohamed ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

^b Mansoura University   (Egypt)

Author keywords

Angiogenesis; CD34; Esophageal carcinoma; MMP9

Indexed keywords

CD34 ANTIGEN; DNA; GELATINASE B;

ADULT; AGED; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; DNA CONTENT; ESOPHAGUS CARCINOMA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADULT; AGED; ANTIGENS, CD34; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 25444472867     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000177244.59591.c3     Document Type: Article

References (31)

1. Elsobky E, El Baz M, Gomha M, et al. Prognostic value of angiogenesis in schistosoma-associated squamous cell carcinoma of the urinary bladder. Urology. 2002;60:69-73.
2. Ahn M-J, Jang S-J, Park Y-W, et al. Clinical prognostic values of vascular endothelial growth factor, microvessel density, and p53 expression in esophageal carcinomas. J Korean Med Sci. 2002;17:201-207.
3. Linde N. Cancer Warrior: "NOVA." Alexandria, VA: PBS, 2001.
4. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990;82:4-6.
5. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med. 2003;3:643-651.
6. Ohashi K, Nemoto T, Nakamura K, et al. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer. 2000;88:2201-2209.
7. Moreto M. Diagnosis of esophagogastric tumors (review) [Review]. Endoscopy. 2001;33:1-7.
8. Hedley DW. Flow cytometry using paraffin-embedded tissue: five years on. Cytometry. 1989;10:229-241.
9. Levi F, La Vecchia C, Te VC. Descriptive epidemiology of adenocarcinoma of the cardia and distal stomach in the Swiss Canton of Vaud. Tumori. 1990;76:167-171.
10. Hansson LE, Sparen P, Nyren O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer. 1993;54:402-407.
11. McKinney PA, Sharp L, Macfarlane GJ, et al. Oesophageal and gastric cancer in Scotland 1960-90. Br J Cancer. 1995;71:411-415.
12. Armstrong RW, Borman B. Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992. Int J Epidemiol. 1996;25:941-947.
13. Lord RVN, Law MG, Ward RL, et al. Rising incidence of oesophageal adenocarcinoma in men in Australia. J Gastroenterol Hepatol. 1998;13:356-362.
14. Dolan K, Sutton R, Walker SJ, et al. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer. 1999;80:834-842.
15. Sugimachi K, Ohno S, Matsoda H, et al. Clinicopathologic study of early stage esophageal carcinoma. Surgery. 1989;105:706-710.
16. Orringer MB, Forastiere AA, Perez-Tomayo Urba S, et al. Chemotherapy and irradiation therapy before transhiatal esophagectomy for esophageal carcinoma. Ann Thorac Surg. 1990;49:348-355.
17. Hui AM, Itabashi M, Kato H, et al. Flow cytometric DNA analysis of submucosal carcinoma of the esophagus. Jpn J Clin Oncol. 1994;24:26-31.
18. Haraguchi Y, Baba M, Takao S, et al. Flow cytometric analysis of DNA heterogeneity in superficial carcinoma of the esophagus. Cancer. 1995;75:914-919.
19. Lam KY, Ma L, Law SY, et al. Use of flow cytometry in the analysis of stage III squamous cell carcinoma of the esophagus and its association with M1B-1. J Clin Pathol. 1996;49:975-978.
20. Kimura H, Konishi M, Yabushita K, et al. Flow cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in submucosal carcinoma of the esophagus. Hepatogastroenterology. 1999;46:285-289.
21. Robaszkiewicz M, Reid BJ, Volant A, et al. Flow cytometric DNA content analysis of esophageal squamous cell carcinomas. Gastroenterology. 1991;101:1588-1593.
22. Reid BJ, Ttaggitt RC, Rubin CE, et al. Barrett's esophagus: correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology. 1987;93:1-11.
23. Sarbia M, Molsberger G, Willers R, et al. The prognostic significance of DNA ploidy in adenocarcinoma as of the esophagogastric junction. J Cancer Res. 1996;122:186-188.
24. Lanza F, Healy L, Sutherland R. Structural and functional features of the CD34 antigen: an update. J Biol Regul Homeost Agents. 2001;15:1-13.
25. Tanigawa N, Amaya H, Matsumura M, et al. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol. 1997;2:826-832.
26. Katadai Y, Haruma K, Tokutomi T, et al. Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res. 1998;4:2195-2200.
27. Guo W, Ran Y, Wang G, et al. Expression and hypoxic regulation of vascular endothelial growth factor and matrix metalloproteinase-9 in esophageal carcinoma. Zhonghua Zhong Liu Za Zhi. 2002;24:44-47.
28. Igarashi M, Dhar DK, Kubota H, et al. The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer. 1998;7:1225-1232.
29. Sato F, Shimada Y, Watanabe G, et al. Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer. Br J Cancer. 1999;80:1366-1372.
30. Samantaray S, Sharma R, Chattopadhyaya TK, et al. Increased expression of MMP-2 and MMP9 in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2004;130:37-44.
31. Klein G, Vellenga E, Fraaije MW, et al. The possible role of matrix metalloproteinase (MMP)-2 and MMP9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol. 2004;50:87-100.